Position in ABBV
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$7,415,326
+$628,116 QoQ
Shares Held
29,468
-5.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
2.58%
of 13F equity value
Holder Rank
#1,070
of 4,153 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 79%
Shared 0%
None 21%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Montecito Bank & Trust holds $27,844,791 across 8 Drug Manufacturers - General names. ABBV ranks #2 (26.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
9,044 | $10,847,645 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
29,468 | $7,415,326 | |
| 3 | JNJ |
Johnson & Johnson
|
17,089 | $4,340,092 | |
| 4 | MRK |
Merck & Co., Inc.
|
21,223 | $2,727,155 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
6,872 | $868,208 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
12,596 | $725,780 | |
| 7 | PFE |
Pfizer Inc
|
26,984 | $649,773 | |
| 8 | NVS |
Novartis AG
|
1,728 | $270,812 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,415,326 | 29,468 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $6,787,210 | 31,207 | Shares | Defined | 2026-04-16 | |
| 2025-12-31 | $7,252,043 | 31,739 | Shares | Defined | 2026-01-09 | |
| 2025-09-30 | $7,948,535 | 34,329 | Shares | Defined | 2025-10-07 | |
| 2025-03-31 | $6,869,951 | 32,789 | Shares | Defined | 2025-04-17 | |
| 2024-12-31 | $5,836,555 | 32,845 | Shares | Defined | 2025-01-21 | |
| 2024-09-30 | $6,531,650 | 33,075 | Shares | Defined | 2024-10-31 | |
| 2024-06-30 | $4,534,302 | 26,436 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $4,882,464 | 26,812 | Shares | Sole | 2024-04-09 | |
| 2023-12-31 | $4,185,584 | 27,009 | Shares | Sole | 2024-01-05 | |
| 2023-09-30 | $4,412,920 | 29,605 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $4,311,359 | 32,000 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $5,214,107 | 32,717 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $5,540,152 | 34,281 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $4,677,217 | 34,850 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $5,634,909 | 36,791 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $8,097,555 | 49,951 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $6,871,008 | 50,746 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $5,381,202 | 49,886 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $5,572,863 | 49,475 | Shares | Sole | 2021-07-08 | |
| 2021-03-31 | $5,319,554 | 49,155 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $5,482,436 | 51,166 | Shares | Sole | 2021-01-28 | |
| 2020-09-30 | $4,333,251 | 49,472 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $4,484,076 | 45,672 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $3,100,704 | 40,697 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||